JP2004224775A5 - - Google Patents

Download PDF

Info

Publication number
JP2004224775A5
JP2004224775A5 JP2003017909A JP2003017909A JP2004224775A5 JP 2004224775 A5 JP2004224775 A5 JP 2004224775A5 JP 2003017909 A JP2003017909 A JP 2003017909A JP 2003017909 A JP2003017909 A JP 2003017909A JP 2004224775 A5 JP2004224775 A5 JP 2004224775A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
agent according
inflammatory agent
inflammatory
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003017909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004224775A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003017909A priority Critical patent/JP2004224775A/ja
Priority claimed from JP2003017909A external-priority patent/JP2004224775A/ja
Publication of JP2004224775A publication Critical patent/JP2004224775A/ja
Publication of JP2004224775A5 publication Critical patent/JP2004224775A5/ja
Pending legal-status Critical Current

Links

JP2003017909A 2003-01-27 2003-01-27 抗炎症剤 Pending JP2004224775A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003017909A JP2004224775A (ja) 2003-01-27 2003-01-27 抗炎症剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003017909A JP2004224775A (ja) 2003-01-27 2003-01-27 抗炎症剤

Publications (2)

Publication Number Publication Date
JP2004224775A JP2004224775A (ja) 2004-08-12
JP2004224775A5 true JP2004224775A5 (enExample) 2006-02-09

Family

ID=32904933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003017909A Pending JP2004224775A (ja) 2003-01-27 2003-01-27 抗炎症剤

Country Status (1)

Country Link
JP (1) JP2004224775A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100291089A1 (en) * 2005-07-07 2010-11-18 Postech Academy-Industry Foundation Ligand of regulating immune response, and use thereof in treating an immune response-related disease
WO2010007175A2 (en) * 2008-07-18 2010-01-21 Galderma Research & Development Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them
US20210154271A1 (en) 2018-01-30 2021-05-27 Shioda Life Science Inc. Corneal epithelial cell chemotaxis promoter
EP3932490B1 (en) * 2019-02-27 2025-04-02 Kagoshima University Antipruritic agent using pac1 receptor antagonist

Similar Documents

Publication Publication Date Title
JP2004515500A5 (enExample)
JP2004523498A5 (enExample)
JP2004529078A5 (enExample)
JP2004532810A5 (enExample)
JP2005526147A5 (enExample)
JP2006503588A5 (enExample)
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
FI20105657L (fi) Farmaseuttisia koostumuksia
FI20011478A0 (fi) Farmaseuttinen koostumus
EE05020B1 (et) Glburiidi ravimkoostis
ATE355271T1 (de) Pharmazeutische zusammensetzung
DK1467724T3 (da) Farmaceutisk sammensætning med agomelatin til dispergering i mundhulen
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
FI20022128A7 (fi) Farmaseuttinen koostumus
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
ATE366128T1 (de) Pharmazeutische zusammensetzung
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
RU2002107079A (ru) Вещество, обладающее седативным действием
JP2008515980A5 (enExample)
JP2004224775A5 (enExample)
DE10291905D2 (de) Pharmazeutische Zusammensetzung
DE602004016751D1 (de) Orodispersible pharmazeutische zusammensetzung einer antithrombotischen verbindung